We are a community of interdisciplinary researchers and clinicians at Tufts University working to tackle cancer.
Upcoming event: Fall 2024 Symposium
Friday November 1st, Breed Hall, 51 Winthrop St, Medford Campus 9-4pm
Register here:
www.eventbrite.com/e/converging-on-cancer-at-tufts-2024-tickets-1031113075967?aff=oddtdtcreator
Submit for a poster presentation here.
Friday November 1st, Breed Hall, 51 Winthrop St, Medford Campus 9-4pm
Register here:
www.eventbrite.com/e/converging-on-cancer-at-tufts-2024-tickets-1031113075967?aff=oddtdtcreator
Submit for a poster presentation here.
PROGRAM
9:00 – Welcome
9:10 – Dr. Sarah Hengel (BIO) - RAD51 paralogs in endometrial/ovarian cancers
9:30 – Dr.Chris Wiley (HNRNCA) - Cellular Senescence and ferroptosis as one-two-punch for cancer therapy
9:50 – Hanan Bloomer - Oudin lab (BME) - Dissecting the role of nerve-tumor crosstalk in breast cancer
10:10 – Dr. Dominique Michaud (Public Health) - DNA methylation patterns and cancer risk: an opportunity to better understand cancer etiology and identify high-risk individuals
10:30 – Coffee break
10:45 – Dr. Richard Travers (Jaffe Lab, MCRI) ‘Understanding the Vascular Toxicity of BCR-ABL Tyrosine Kinase Inhibitors)
11:05 – Dr. Elizabeth White (DMCB) - Papillomavirus oncoproteins reprogram host cell fate
11:25 – Dr. Isaac Gendelman, Schnelldorfer lab (Surgery) - What does cancer look like? A Report from the Surgical Imaging Lab
11:45 – Dr. Nate Richbourg, Peyton lab (BME) - Modeling environmental triggers of breast cancer dormancy and reawakening
12:05 – Dr. Heather Gardner (Vet School) - Multi-omic tissue and plasma assessment to identify biomarkers of disease progression in osteosarcoma
12:25 – Lunch - light refreshments will be served
1-2PM – Poster session
2:00 – Dr. Joshua Kritzer (CHEM) - Controlling Autophagy for Cancer Therapy and Targeted Protein Degradation
2:20 - Dr. Jaye Gardiner (BIO) - Role of the BAF Complex in Pancreatic Cancer-Associated Fibroblast Function
2:40 – Dr. Karl Munger lab (DMCB)- Non-protein targets and Effects of HPV Oncoproteins
3:00 – Dr. Juanita Matthews (BIO) -Ion channel drugs suppress cancer phenotype in glioblastoma
3:20 – Dr. Gat Rauner (GMCB)- Engineering Organoid Models to Study Breast Cancer
3:40 – Dr. Srivalleesha Mallidi (BME) - Utility of oxygenated nanodroplets and ultrasound-guided photoacoustic imaging for cancer therapy
POSTERS
9:00 – Welcome
9:10 – Dr. Sarah Hengel (BIO) - RAD51 paralogs in endometrial/ovarian cancers
9:30 – Dr.Chris Wiley (HNRNCA) - Cellular Senescence and ferroptosis as one-two-punch for cancer therapy
9:50 – Hanan Bloomer - Oudin lab (BME) - Dissecting the role of nerve-tumor crosstalk in breast cancer
10:10 – Dr. Dominique Michaud (Public Health) - DNA methylation patterns and cancer risk: an opportunity to better understand cancer etiology and identify high-risk individuals
10:30 – Coffee break
10:45 – Dr. Richard Travers (Jaffe Lab, MCRI) ‘Understanding the Vascular Toxicity of BCR-ABL Tyrosine Kinase Inhibitors)
11:05 – Dr. Elizabeth White (DMCB) - Papillomavirus oncoproteins reprogram host cell fate
11:25 – Dr. Isaac Gendelman, Schnelldorfer lab (Surgery) - What does cancer look like? A Report from the Surgical Imaging Lab
11:45 – Dr. Nate Richbourg, Peyton lab (BME) - Modeling environmental triggers of breast cancer dormancy and reawakening
12:05 – Dr. Heather Gardner (Vet School) - Multi-omic tissue and plasma assessment to identify biomarkers of disease progression in osteosarcoma
12:25 – Lunch - light refreshments will be served
1-2PM – Poster session
2:00 – Dr. Joshua Kritzer (CHEM) - Controlling Autophagy for Cancer Therapy and Targeted Protein Degradation
2:20 - Dr. Jaye Gardiner (BIO) - Role of the BAF Complex in Pancreatic Cancer-Associated Fibroblast Function
2:40 – Dr. Karl Munger lab (DMCB)- Non-protein targets and Effects of HPV Oncoproteins
3:00 – Dr. Juanita Matthews (BIO) -Ion channel drugs suppress cancer phenotype in glioblastoma
3:20 – Dr. Gat Rauner (GMCB)- Engineering Organoid Models to Study Breast Cancer
3:40 – Dr. Srivalleesha Mallidi (BME) - Utility of oxygenated nanodroplets and ultrasound-guided photoacoustic imaging for cancer therapy
POSTERS
- Marzieh Naseri, Moore lab, Boston Health Sciences Campus Targeting the mRNA 3’ end processing endonuclease, CPSF37: a novel approach to impeded the invasiveness of cancer cells
- Crystal Zhang, Oudin lab, Department of Biomedical Engineering, Role of the Resting Membrane Potential in Triple Negative Breast Cancer Metastasis
- Abigail Lebovitz and Tamara Vesel, Division of Palliative Care, Tufts Medical Center, Use of Ketamine for Cancer Related Pain in the Ambulatory Setting
- Meadow Parrish, Kuperwasser lab, Boston Health Sciences Campus, Exploring the effects of endocrine disruption + DNA damage on breast development and carcinogenic potential
- Ana Dias, McVey Lab, Department of Biology, Genetic Screening Reveals Critical Roles for Drosophila melanogaster Polymerase Eta and CG7139 in DNA Alkylation Damage Tolerance
- Artem Arkhangelskiy, Kaplan lab, Department of Biomedical Engineering, Electric and Magnetic Fields Therapy for Glioblastoma Multiforme: Tumor Treating Fields Approach
- Maya Gelbard, Munger lab, Boston Health Sciences Campus, Investigating the biochemical targets and biological activities of the HPV101 E7 protein
- Ivy Le, Van Deventer lab, Department of Chemical and Biological Engineering, Exploring Irreversible Protease Inhibition: Using Yeast Surface Display and Genetic Code Expansion to Engineer Covalent MMP-9 Inhibitors
- Michael Rist, Coffin lab, Boston Health Sciences Campus, Ex vivo HIV DNA integration in STAT3 drives T cell persistence—A model of HIV-associated T cell lymphoma
- Anna Yui, Oudin lab, Department of Biomedical Engineering, Chemotherapy directly drives fibroblast activation and increased ECM production to drive invasion and recurrence in breast cancer
- Clara Fritz, Mendez lab, Boston Health Sciences Campus, Unraveling the Assembly and Localization of Kaposi Sarcoma Associated Herpes Virus Primosome Complex
- Mili Das, Freudenreich lab, Department of Biology, DNA polymerase zeta can replicate through structures formed by AT repeat sequences and prevent their deletion
- Kerstin Seidel, Gardner lab, Tufts Vet School, Characterizing mutations of the histone methyltransferase SETD2 in canine osteosarcoma
- Brent Cochran, Boston Health Sciences Campus, Modeling glioblastoma stem cell heterogeneity with a dynamic causal model of the cell signaling network
- Srimoyee Mukherjee, Moore lab, Boston Health Sciences Campus, Alternative Polyadenylation Regulator CFIm25 Drives M1 Macrophage Polarization via AKT2 Modulation
